Circulating Tumor DNA‐Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma

PURPOSE: Recent advances in molecular diagnostic technologies allow for the evaluation of solid tumor malignancies through noninvasive blood sampling, including circulating tumor DNA profiling (ctDNA). Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, often because of late presentation o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncologist
Autori principali: Botrus, Gehan, Kosirorek, Heidi, Sonbol, Mohamad Bassam, Kusne, Yael, Uson Junior, Pedro Luiz Serrano, Borad, Mitesh J., Ahn, Daniel H., Kasi, Pashtoon M., Drusbosky, Leylah M., Dada, Hiba, Surapaneni, Phani Keerthi, Starr, Jason, Ritter, Ashton, McMillan, Jessica, Wylie, Natasha, Mody, Kabir, Bekaii‐Saab, Tanios S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2021
Soggetti:
Gastrointestinal Cancer
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8265372/
https://ncbi.nlm.nih.gov/pubmed/33555095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13717
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi